Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the FDA.

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...

The ad from the telehealth company Hims & Hers promoted the company’s compounded weight loss drugs. The ad portrayed the obesity epidemic as a rigged game because of the greedy health care system. Dr.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

CNBC's Brandon Gomez joins 'Squawk on the Street' to break down the controversy around Hims & Hers Super Bowl ads.

prescription topicals for acne and aging, and a bevy of other treatments that cover weight loss, sexual wellness, and mental health. Hims has also largely expanded its hair loss treatments ...

Even if your insurance covers the bulk of the expenses, you may have to jump through prior authorization hoops. Telehealth company Hims & Hers has had enough—and is putting its money where its mouth ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...